Price
No data yet.
Social Signal Score
Revenue
$3.32M+1169.60%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Arnon Rosenthal
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 103
- Beta
- 0.58
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -7.26
Financials
Revenue
$3.32M+1169.6%Net Income
$-22.99MEBITDA
$-18.73MFree Cash Flow
$-34.25MEPS (diluted)
$-0.21Shares Outstanding (diluted)
111.22M+1208.9%Operating Expenses
$27.71MCash & Debt
$172.80MReturn of Capital
$0.00Revenue by Segment (annual)
$173.40MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $21.05M | $-142.93M | $-1.39 |
| 2024 | $100.56M | $-119.05M | $-1.23 |
| 2023 | $97.06M | $-130.39M | $-1.56 |
| 2022 | $133.62M | $-133.31M | $-1.62 |
| 2021 | $207.09M | $-36.33M | $-0.45 |
| 2020 | $21.10M | $-190.23M | $-2.45 |
| 2019 | $21.22M | $-105.39M | $-1.62 |
| 2018 | $27.68M | $-52.25M | $-0.76 |
| 2017 | $3.73M | $-32.48M | $-0.63 |
| 2016 | $416.0K | $-15.11M | $-1.78 |
Valuation
ALEChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsglobenewswire.com·1d ago·Neutral
Alector to Participate in Upcoming Healthcare Conferences SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences: Cantor Global Healthcare Conference 2026 (New York, New York) Thursday, September 10, 2026, at 2:10 p.m.
View source ↗
Earnings
Thu, Nov 5(in 2 months)
Consensus estimate $-0.24 per share
Typical surprise +19.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.21 vs $-0.23beat
- Thu, May 7$-0.21 vs $-0.35beat
- Wed, Feb 25$-0.34 vs $-0.39beat
- Thu, Nov 6$-0.34 vs $-0.42beat
- Thu, Aug 7$-0.30 vs $-0.45beat
- Thu, May 8$-0.41 vs $-0.44beat
Estimates and results for ALEC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ALEC officers and directors.
- Bought
- —
- Sold
- $1.9m
0 trades
36 trades
- Wong-sarad Gracesold
- Wong-sarad Gracesold
- Wong-sarad Gracesold
- Wong-sarad Gracesold
- Rosenthal Arnonsold
- Berkley Neil Lindsaysold
- Wong-sarad Gracesold
- Wong-sarad Gracesold
64 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.